TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: DAS28‐ESR low disease activity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight loss after childbirth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 to 5 treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Increase in palliative care knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in attitudes towards palliative care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in left ventricular end-systolic volume (LVESV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: patient-reported treatment result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal satisfaction (mean visual analogue scale score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete and durable responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year success rate of full pulpotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fistula distribution and recurrence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of Holdemanella
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IP-10 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum IL-27 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum ICAM-1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serum VCAM-1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Overall PMABS-ICU score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood loss
Endpoint domain: Adverse events/effects
Primary endpoint: Urothelial injury
Endpoint domain: Adverse events/effects
Primary endpoint: Change in fluorescein corneal staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic hypocalcemia rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical hypocalcemia rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Alzheimer's Disease (AD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of renal failure (RF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative temporary pacing use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ADHD-RS-IV total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration/attention factor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of completed classes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: selected grade ≥ 3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Late rectal α/β ratio
Endpoint domain: Adverse events/effects
Primary endpoint: Pain tolerance in men
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity in women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Executive function measured by Trail Making Test Part B
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stiffness index of bone quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: jumping performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of supraventricular ectopic beats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: children's CN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregivers' CN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vegetable consumption
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: life satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: hope and resilience score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Success rates of treatment for gonorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment of NG-CT co-infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short-form 6-dimension medical outcome questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Euro-thermometer visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time trade-off
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum BHB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average E/e'
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of therapeutic embolization for arterial injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Contrast agent requirement at the time of EA
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Transfusion requirement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: JIA-ACR50 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median JADAS-71 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving inactive disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular injury frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Complete healing of artificial mucosal defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in draining fistulae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal Disease Activity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inpatient mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: maximum compression force delivered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: HIV screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Degree of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RPE values
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: uterine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uterine artery blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily sunscreen use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin self-examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Use of tanning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Favorable 6-month Glasgow Outcome Scale Extended outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Insertion success rate of I-Gel®
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean capnometric values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radicular pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability (Oswestry Disability Index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Craniomandibular index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of use of NG
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for NG over IG
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Workload required to administer glucagon
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IPSS QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Qmax values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum PGI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum PGII levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cognition improvement (ADAS-Cog)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patients’ subjective degree of satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall behavior improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neuroprotective effect on the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUCinf and Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of reliable uroflowmetry tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voided volume over 150 mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes-related distress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: worst CIPN pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bile duct and liver fluorescence intensity (FI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biliary luminal ratio (BLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total cholesterol change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Oswestry Disability Index values
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Decisional clarity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: MIP improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6MWT distance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Median Urinary Iodine Concentration (UIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median Thyroglobulin (Tg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: percentage of participants losing ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants losing ≥7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SBM count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post test score for fracture classification and surgical approach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KCCQ‐TS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: KCCQ‐PL scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: immediate retention of technical ECM skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: forgone care due to costs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: having a usual source of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cumulative amount of opioids consumed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Wound-specific quality of life improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Antibody concentration (GMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: index of success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of NRS reduction to less than three points in 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial TRL-apo(a) AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: amygdala threat reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: amygdala desensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean difference in change in sitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total checklist score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-confidence in tourniquet placement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Transfer of bacteriophage MS2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Need for upper GI tract endoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to the 6-week exercise program
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median time required to insert the NGT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of procedure-related injuries
Endpoint domain: Adverse events/effects
Primary endpoint: ≥30% NDI-5 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause death/myocardial infarction/unstable angina hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: cardiovascular death/MI
Endpoint domain: Mortality/survival
Primary endpoint: mean quality-adjusted life-year (QALY) gain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: haemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean whole-liver dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain interference
Endpoint domain: Life impact
Endpoint subdomain: Pain interference
Primary endpoint: total vBMD at the distal tibia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: cortical vBMD at the distal radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: estimated failure load at tibia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and lymphatic system outcomes
Primary endpoint: Mean time from diagnosis to chemotherapy initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual working memory recall performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: recall accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: normal DO2 after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total hemoglobin concentration ([tHb])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: NIHSS knowledge acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in knee pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in medial tibial cartilage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scalp–Cortex distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NOT (Neuromuscular blockade reversal time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood lactate response to running
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Low density-lipoprotein cholesterol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in CAINS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of flumatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0–t of flumatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0–∞ of flumatinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving the combined lipid goal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kaplan-Meier survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of participants with glycated hemoglobin level < 7.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 90-day mRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of gastric neoplastic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 1-year AF free survival
Endpoint domain: Mortality/survival
Primary endpoint: SUA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2h‐AUC ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Uric acid index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: stone disintegration time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: incidence of self-limiting hematuria
Endpoint domain: Adverse events/effects
Primary endpoint: Hematoma expansion at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Unfavorable functional outcome (modified Rankin Scale score 4 to 6 at 90 days)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: fear-avoidance of physical activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fear of movement scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Canadian occupational performance and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: physical strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRP levels on postoperative day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to quit for self
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Desire to quit for partner
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Likelihood of quitting together in the next 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient waiting time
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Clinicians' adherence to malaria test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of LCS consumers in trimester 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA‐UE motor score difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment success in toxin-related benzodiazepine-refractory status epilepticus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental cost of standard dressing versus iNPWT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: QALYs gained in the iNPWT group
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Depigmenting effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in hair growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean number of agenda items discussed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPA fall risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ABC (Activities-specific Balance Confidence)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Upper limb function recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interhemispheric asymmetry reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) of plasma cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes